Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-May-23 5:00 PM View:  | Allovir, Inc. (ALVR) | 11-May-23 | Grant | 35,000 | -- | -- | < 1% 19.61M to 19.64M | |
| 21-Oct-22 9:30 PM View: | Allovir, Inc. (ALVR) | 19-Oct-22 | Sale | 600,000 | $8.45 | $5,070,000.00 | (3%) 20.21M to 19.61M | |
| 30-Sep-22 4:05 PM View: | Allovir, Inc. (ALVR) | 29-Sep-22 | Sale | 400,000 | $7.35 | $2,940,920.00 | (2%) 20.61M to 20.21M | |
| 01-Aug-22 4:38 PM View: | Allovir, Inc. (ALVR) | 28-Jul-22 | Grant Duplicate | 3,253,800 | $4.61 | $15,000,000.00 | 19% 17.35M to 20.61M | |
| 21-Jul-22 7:13 PM View: | Allovir, Inc. (ALVR) | 21-Jul-22 | Sale (Planned) | 4,227 | $5.33 | $22,527.80 | (< 1%) 17.36M to 17.35M | |
| 17-Jun-22 6:36 PM View: | Seer, Inc. (SEER) | 15-Jun-22 | Grant | 9,945 | -- | -- | 4% 263.56K to 273.51K | |
| 10-Jun-22 7:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 09-Jun-22 | Option Exercise | 1,171 | $4.23 | $4,953.33 | 100% 0 to 1.17K | |
| 10-Jun-22 7:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 09-Jun-22 | Option Sale | 1,171 | $19.51 | $22,846.20 | (100%) 1.17K to 0 | |
| 10-Jun-22 7:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 08-Jun-22 | Option Exercise | 28,444 | $3.69 | $105,087.00 | 100% 0 to 28.44K | |
| 10-Jun-22 7:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 08-Jun-22 | Option Sale | 28,444 | $20.19 | $574,367.00 | (100%) 28.44K to 0 | |
| 06-Jun-22 4:05 PM View: | Allovir, Inc. (ALVR) | 03-Jun-22 | Sale (Planned) | 65,725 | $3.67 | $241,106.00 | (< 1%) 17.42M to 17.36M | |
| 22-Apr-22 8:31 AM View: | Allovir, Inc. (ALVR) | 21-Apr-22 | Sale (Planned) | 4,227 | $5.87 | $24,812.50 | (< 1%) 17.43M to 17.42M | |
| 11-Mar-22 7:14 PM View: | Allovir, Inc. (ALVR) | 11-Mar-22 | Sale (Planned) | 25,244 | $7.37 | $186,068.00 | (< 1%) 17.45M to 17.43M | |
| 11-Mar-22 7:14 PM View: | Allovir, Inc. (ALVR) | 10-Mar-22 | Sale (Planned) | 40,481 | $7.55 | $305,781.00 | (< 1%) 17.49M to 17.45M | |
| 25-Jan-22 4:15 PM View: | Allovir, Inc. (ALVR) | 24-Jan-22 | Sale | 17,100 | $8.01 | $136,889.00 | (< 1%) 17.51M to 17.49M | |
| 22-Dec-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 20-Dec-21 | Option Exercise | 50,000 | $3.49 | $174,500.00 | 100% 0 to 50.0K | |
| 22-Dec-21 7:59 PM View: | Iteos Therapeutics, Inc. (ITOS) | 20-Dec-21 | Market Option Sale | 50,000 | $43.57 | $2,178,500.00 | (100%) 50.0K to 0 | |
| 25-Jan-21 5:04 PM View: | Allovir, Inc. (ALVR) | 21-Jan-21 | Grant | 147,000 | -- | -- | < 1% 17.36M to 17.51M | |
| 05-Aug-20 9:56 PM View: | Allovir, Inc. (ALVR) | 03-Aug-20 | Conversion | 14,315,700 | -- | -- | 470% 3.05M to 17.36M | |
| 20-Sep-19 4:39 PM View: | Scholar Rock Holding Corp (SRRK) | 18-Sep-19 | Gift | 2,000 | -- | -- | (< 1%) 292.6K to 290.6K | |
| 10-Aug-16 6:22 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Aug-16 | Market Sale | 332 | $137.14 | $45,530.50 | (< 1%) 189.6K to 189.27K | (31%) |
| 05-Apr-16 5:26 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 01-Apr-16 | Market Sale | 1,414 | $135.88 | $192,132.00 | (< 1%) 191.01K to 189.6K | (32%) |
| 01-Mar-16 6:32 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Feb-16 | Market Sale | 2,014 | $138.93 | $279,800.00 | (1%) 193.03K to 191.01K | (30%) |
| 01-Mar-16 6:32 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 26-Feb-16 | Grant | 20,000 | -- | -- | 12% 173.03K to 193.03K | |
| 08-Feb-16 7:57 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-16 | Market Sale | 3,946 | $138.05 | $544,763.00 | (2%) 176.97K to 173.03K | (30%) |
| 08-Feb-16 7:57 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-16 | Market Sale | 6,722 | $141.63 | $952,043.00 | (4%) 183.69K to 176.97K | (27%) |
| 08-Feb-16 7:57 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Grant | 41,136 | -- | -- | 29% 143.19K to 184.32K | |
| 08-Feb-16 7:57 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Market Sale | 629 | $143.83 | $90,468.90 | (< 1%) 184.32K to 183.69K | (25%) |
| 11-Aug-15 5:53 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Aug-15 | Market Sale | 329 | $190.01 | $62,513.30 | (< 1%) 143.52K to 143.19K | 5% |
| 05-Aug-15 6:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Aug-15 | Market Sale | 612 | $196.52 | $120,270.00 | (< 1%) 144.13K to 143.52K | 8% |
| 02-Apr-15 6:15 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 31-Mar-15 | Grant | 11,270 | -- | -- | 8% 132.86K to 144.13K | |
| 03-Mar-15 9:11 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Mar-15 | Market Sale | 730 | $180.34 | $131,648.00 | (< 1%) 133.59K to 132.86K | < 1% |
| 03-Mar-15 9:11 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-15 | Grant | 9,555 | -- | -- | 8% 124.03K to 133.59K | |
| 12-Feb-15 9:06 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Feb-15 | Market Sale | 1,980 | $171.15 | $338,877.00 | (2%) 126.01K to 124.03K | (5%) |
| 09-Feb-15 8:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-Feb-15 | Market Sale | 2,920 | $173.93 | $507,876.00 | (2%) 128.93K to 126.01K | (3%) |
| 09-Feb-15 8:46 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-15 | Grant | 11,690 | -- | -- | 10% 117.24K to 128.93K | |
| 05-Feb-15 8:10 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-15 | Market Sale | 608 | $174.38 | $106,023.00 | (< 1%) 117.85K to 117.24K | (3%) |
| 05-Feb-15 8:10 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Feb-15 | Market Sale | 765 | $174.02 | $133,125.00 | (< 1%) 118.62K to 117.85K | (3%) |
| 19-Dec-14 4:49 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 18-Dec-14 | Market Sale (Planned) | 5,494 | $182.03 | $1,000,070.00 | (5%) 118.62K to 113.12K | 1% |
| 04-Nov-14 6:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Nov-14 | Option Exercise | 30,000 | $20.39 | $611,736.00 | 25% 118.62K to 148.62K | |
| 04-Nov-14 6:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Nov-14 | Market Option Sale | 30,000 | $190.01 | $5,700,290.00 | (20%) 148.62K to 118.62K | 5% |
| 05-Aug-14 4:55 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Aug-14 | Market Sale | 1,349 | $158.00 | $213,142.00 | (1%) 119.97K to 118.62K | (14%) |
| 04-Mar-14 5:34 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-14 | Grant | 6,000 | -- | -- | 5% 113.97K to 119.97K | |
| 10-Feb-14 6:47 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Feb-14 | Market Sale | 1,610 | $155.57 | $250,461.00 | (1%) 115.58K to 113.97K | (16%) |
| 10-Feb-14 6:47 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-14 | Grant | 9,745 | -- | -- | 9% 104.23K to 113.97K | |
| 10-Feb-14 6:47 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-14 | Market Sale | 10 | $156.95 | $1,569.50 | (< 1%) 113.97K to 113.97K | (15%) |
| 05-Feb-14 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-14 | Market Sale | 2,390 | $153.63 | $367,176.00 | (2%) 108.22K to 105.83K | (17%) |
| 05-Feb-14 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Feb-14 | Market Sale | 729 | $157.14 | $114,555.00 | (< 1%) 108.95K to 108.22K | (15%) |
| 31-Jan-14 5:29 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Jan-14 | Market Sale | 729 | $133.45 | $97,282.70 | (< 1%) 109.68K to 108.95K | (35%) |
| 20-Dec-13 4:25 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 18-Dec-13 | Grant | 15,363 | $17.98 | $276,227.00 | 7% 219.36K to 234.72K |